The authors of “Safety and Efficacy of Extended Therapy with [177Lu]Lu-PSMA: A German Multicenter Study” include Robert Seifert, Department of Nuclear Medicine, University Hospital Essen, Essen, Germany, German Cancer Consortium, University Hospital Essen, Essen, Germany, West German Cancer, University Hospital Essen, Essen, Germany, Department of Nuclear Medicine, University Hospital Bern, Bern, Switzerland, and Department of Nuclear Medicine, University Hospital Münster, Münster, Germany; Tugce Telli, Mélanie Desaulniers, Ken Herrmann, and Wolfgang P. Fendler, Department of Nuclear Medicine, University Hospital Essen, Essen, Germany, German Cancer Consortium, University Hospital Essen, Essen, Germany, and West German Cancer, University Hospital Essen, Essen, Germany; Constantin Lapa and Christian Pfob, German Cancer Consortium, University Hospital Essen, Essen, Germany, and Department of Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany; Turkay Hekimsoy, Wolfgang A. Weber, and Matthias Eiber, German Cancer Consortium, University Hospital Essen, Essen, Germany, Department of Nuclear Medicine, Klinikum Rechts der Isar, Technical University Munich, Munich, Germany, and Bavarian Cancer Research Center, Erlangen, Germany; Boris Hadaschik, German Cancer Consortium, University Hospital Essen, Essen, Germany, West German Cancer, University Hospital Essen, Essen, Germany, and Department of Urology, University Hospital Essen, Essen, Germany; Martin Bögemann, West German Cancer, University Hospital Essen, Essen, Germany, and Department of Urology, University Hospital Münster, Münster, Germany; and Michael Schäfers and Kambiz Rahbar, West German Cancer, University Hospital Essen, Essen, Germany, and Department of Nuclear Medicine, University Hospital Münster, Münster, Germany.
Visit the JNM website for the latest research, and follow our new Twitter and Facebook pages @JournalofNucMed or follow us on LinkedIn.
###
Please visit the SNMMI Media Center for more information about molecular imaging and precision imaging. To schedule an interview with the researchers, please contact Rebecca Maxey at (703) 652-6772 or [email protected].
About JNM and the Society of Nuclear Medicine and Molecular Imaging
The Journal of Nuclear Medicine (JNM) is the world’s leading nuclear medicine, molecular imaging and theranostics journal, accessed more than 16 million times each year by practitioners around the globe, providing them with the information they need to advance this rapidly expanding field. Current and past issues of The Journal of Nuclear Medicine can be found online at http://jnm.snmjournals.org.
JNM is published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), an international scientific and medical organization dedicated to advancing nuclear medicine and molecular imaging—precision medicine that allows diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes. For more information, visit www.snmmi.org.